Evidence map›Paper›PMID 26046000›Full record

ArticleAmerican journal of cancer research2015

Increased expression of iASPP correlates with poor prognosis in FIGO IA2-IIA cervical adenocarcinoma following a curative resection.

Fanming Kong, Xiaofeng Shi, Huzi Li, Pu Li, Jianchun Yu, XiaoJiang Li, Jun Chen, Yiyu Sun, Yingjie Jia

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fanming KongDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Xiaofeng ShiDepartment of ICU, Tianjin First Center Hospital Fukang Road, Tianjin 300192, China.
Huzi LiDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Pu LiDepartment of Oncology, Tianjin Central Hospital of Gynecology Obstetrics Changjiang Road, Nankai District, Tianjin 300100, China.
Jianchun YuDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
XiaoJiang LiDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Jun ChenDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Yiyu SunDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Yingjie JiaDepartment of Oncology, First Teaching Hospital of Tianjin University of TCM Anshanxi Road, Nankai District, Tianjin 300193, China.
Tianjin First Center Hospital · CNTianjin Nankai Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe function of iASPP (inhibitory member of the ASPP family) in cervical adenocarcinoma remains unknown. The aim of this study was to explore the expression and clinical relevance of iASPP in early stage cervical adenocarcinoma. Methods The clinical data of 75 patients with FIGO stage IA2-IIA cervical adenocarcinoma who were treated with radical hysterectomy from January 2004 to March 2008 was collected. The mRNA and protein expression levels of iASPP from the paired tumor specimens and adjacent normal cervical tissues were determined by real-time qRT-PCR and Western blot, and its relationship with clinicopathologic factors and prognosis of cervical cancer patients was retrospectively analyzed.

resultsThe mRNA and protein expression levels of iASPP were significantly elevated in cervical cancer tissues. The increased iASPP expression was correlated strongly with higher FIGO staging (p = 0.034), worse differentiation (p = 0.046), less pelvic lymph node metastasis (p = 0.014), and poor overall and disease-free survival of patients with cervical cancer (both P > 0.05). Multivariate Cox analysis indicated that high iASPP expression was an independent prognostic factor (P > 0.05).

conclusionsThis study demonstrates that iASPP is highly elevated in cervical adenocarcinoma, and that overexpression is an independent poor prognostic indicator for early stage cervical cancer patients, suggesting that iASPP might serve as a novel potential prognostic marker and therapeutic target for cervical adenocarcinoma.

Indexed as

Cervical adenocarcinomaiASPPprognostic factorsradical hysterectomy

Identifiers

PMID26046000
PMCPMC4449449
OpenAlexW644189540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.